UVA Health discusses the bivalent vaccine
Published: Sep. 7, 2022 at 5:54 PM EDT|Updated: Sep. 8, 2022 at 10:41 AM EDT
CHARLOTTESVILLE, Va. (WVIR) - UVA Health is discussing the Pfizer and Moderna omicron-specific boosters.
The FDA authorized and the CDC endorsed the use of MRNA vaccines from both companies containing two targets: The original 2020 COVID-19 strain and the omicron BA4BA5 subvariant.
“The hope is that since it’s targeting these two strains, that it actually provides a breadth of immunity with a tried and true COVID vaccine,” Doctor Costi Sifri with UVA Health said.
The vaccine is being called bivalent, because it targets two different COVID-19 variants.
Do you have a story idea? Send us your news tip here.
Copyright 2022 WVIR. All rights reserved.
/cloudfront-us-east-1.images.arcpublishing.com/gray/AKXXDIIDQZEUBMPPT56VL2752E.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/GBMNXCLX6RGRLA5GUIZHSYVTBY.jpeg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/JRV7J47E2VGMVMFGEO5YX56PI4.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/JDFQFB6J4VEJJJQKE6UEX7FKTE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/GBUUCP64VRDOZLO7ROXMLXPYOE.bmp)
/cloudfront-us-east-1.images.arcpublishing.com/gray/RT35UJ2TVBCJ7EWMGEOODIYW4E.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/47C7ZDKZWFB3VJDOD6VPYCN2XQ.png)
/cloudfront-us-east-1.images.arcpublishing.com/gray/XBVG2NOTEBFCNOQ5H4RR4FAB44.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/VVQLI4ZSTFAFJGOZ6CUZW32PK4.jpg)